Don’t Derail Drug Development: Common Issues to Identify and Avoid with a First-Rate Quality Process

Quality encompasses adherence to regulatory compliance, which includes ensuring the safety and efficacy of pharmaceutical supplies, product development, and regulatory improvement, and maintaining an uninterrupted supply chain. In this webcast, Syner-G BioPharma Group’s Director of Quality Assurance and Compliance, Bryan Abney, will discuss the importance of identifying the most common issues that can derail drug development and will advise on how to avoid them while implementing and maintaining excellent Quality processes.